Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

tRNA Activation02:26

tRNA Activation

17.9K
Aminoacyl-tRNA synthetases are present in both eukaryotes and bacteria. Though eukaryotes have 20 different aminoacyl-tRNA synthetases to couple to 20 amino acids, many bacteria do not have genes for all of these aminoacyl-tRNA synthetases. Despite this, they still use all 20 amino acids to synthesize their proteins. For instance, some bacteria do not have the gene encoding the enzyme that couples glutamine with its partner tRNA. In these organisms, one enzyme adds glutamic acid to all of the...
17.9K
tRNA Activation02:26

tRNA Activation

7.5K
7.5K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

80
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
80
Transfer RNA Synthesis02:36

Transfer RNA Synthesis

10.2K
One of the unique features of tRNA is the presence of modified bases. In some tRNAs, modified bases account for nearly 20% of the total bases in the molecule. Altogether, these unusual bases protect the tRNA from enzymatic degradation by RNases.
Each of these chemical modifications is carried by a specific enzyme, post-transcription. All of these enzymes have unique base and site-specificity. Methylation, the most common chemical modification, is carried by at least nine different enzymes, with...
10.2K
ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

15.8K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
15.8K
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

4.8K
Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
4.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The impact of cardiovascular risk factors in non-classical Fabry disease.

Orphanet journal of rare diseases·2026
Same author

Treatment goals for adults with early treated PKU should be determined by evidence-based shared decision making between patients and their medical team.

Orphanet journal of rare diseases·2026
Same author

Histidine Supplementation Stabilizes Hearing and Vision and Improves Growth in HARS1-Related Autosomal Recessive Disorder Associated With Usher-Like Symptoms.

American journal of medical genetics. Part A·2026
Same author

Effectiveness of Riboflavin in Inherited Metabolic Diseases: A Systematic Review.

Journal of inherited metabolic disease·2026
Same author

Serum NfL, GFAP, and p-tau217 in adults with drug-resistant epilepsy and intellectual disabilities: Signs of ongoing neural injury.

Epilepsia·2026
Same author

Mistranslation from an endogenous tRNA variant in human pan-genome cell lines.

Nucleic acids research·2026

Related Experiment Video

Updated: Apr 25, 2026

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
08:04

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

1.5K

Aminoacyl-tRNA Synthetases: Variant Classification, Functional Assays, and Emerging Therapeutic Strategies.

M I Mendes1,2, D E Smith1,2, V Spek1,2

  • 1Laboratory Genetic Metabolic Diseases, Department of Laboratory Medicine, Amsterdam UMC Location University of Amsterdam, Amsterdam, the Netherlands.

Journal of Inherited Metabolic Disease
|April 24, 2026
PubMed
Summary

Aminoacyl-tRNA synthetase (aaRS) gene variants cause diverse human diseases. A new assay aids variant classification, improving diagnosis and guiding targeted therapies for these essential protein synthesis enzymes.

More Related Videos

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

10.2K
Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
06:33

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis

Published on: June 9, 2018

7.2K

Related Experiment Videos

Last Updated: Apr 25, 2026

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
08:04

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

1.5K
Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

10.2K
Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
06:33

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis

Published on: June 9, 2018

7.2K

Area of Science:

  • Biochemistry
  • Genetics
  • Molecular Biology

Background:

  • Aminoacyl-tRNA synthetases (aaRS) are crucial enzymes for protein synthesis.
  • All 37 nuclear-encoded ARS genes are linked to human diseases, presenting varied phenotypes.
  • Functional validation of identified ARS variants is challenging, with many classified as Variants of Unknown Significance (VUS).

Purpose of the Study:

  • To develop and implement a high-throughput functional assay for aaRS activity in patient-derived cells.
  • To improve the classification of genetic variants in ARS genes.
  • To explore the role of non-canonical aaRS functions in disease pathogenesis.

Main Methods:

  • Development of a high-throughput liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based aminoacylation assay.
  • Measurement of aaRS enzymatic activity in patient-derived fibroblasts.
  • Integration of functional assay data with genetic variant information.

Main Results:

  • The assay facilitated the diagnosis of nearly 200 patients with ARS-related disorders.
  • Complex variant effects, such as thermolability and splicing defects, were uncovered.
  • The functional approach aids in classifying VUS and understanding disease mechanisms.

Conclusions:

  • Integrated genomic and functional approaches are essential for accurate variant interpretation in ARS genes.
  • Functional assays are critical for diagnosing patients and guiding personalized treatment strategies.
  • Further research into non-canonical aaRS functions and natural history studies is needed for therapeutic development.